Barclays analyst Manav Patnaik maintains MSCI (NYSE:MSCI) with a Overweight and raises the price target from $600 to $700.
Barclays raises MSCI (NYSE:MSCI) price target from $600 to $700 Read Post »
By Steve Gelsi Analyst recommends GS, JEF, as well as BAC, C, JPM, MS and USB Oppenheimer analyst Chris Kotowski has reiterated overweight ratings on Goldman Sachs Group Inc. and Jefferies Financial Group Inc. as standouts among a class of relatively cheap big-bank stocks. “You wouldn’t know it from the stock market…but big banks did fine in 2023,” Kotowski said in a research note published Tuesday. He’s recommending that investors “in particular” overweight their exposure to Goldman Sachs Group Inc. (GS) and Jefferies (JEF), but the entire group including Bank of America Corp. (BAC), Citigroup Inc. (C), JPMorgan Chase & Co. (JPM), Morgan Stanley (MS) and U.S. Bancorp (USB) “remains significantly undervalued,” he said. The positive note from Oppenheimer came as Morgan Stanley analyst Analyst Betsy Graseck said she is “back & bullish” on big banks. Also read: Morgan Stanley upgrades Bank of America, Goldman Sachs and Citi on ‘lightened
Goldman Sachs, Jefferies Stand Out Among Undervalued Big Banks, Oppenheimer Says Read Post »
Oppenheimer Raises MSCI Price Target to $659 From $601, Maintains Outperform Rating.
Oppenheimer Raises MSCI Price Target to $659 From $601 Read Post »
Franklin Resources (NYSE:BEN) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 10.93% BMO Capital $27 → $30 Maintains Market Perform 01/19/2024 -11.26% Morgan Stanley $22 → $24 Maintains Underweight 01/10/2024 10.93% UBS $26 → $30 Maintains Neutral 01/08/2024 10.93% Wells Fargo $24 → $30 Upgrades Underweight → Equal-Weight 01/04/2024 18.32% TD Cowen → $32 Initiates Coverage On → Market Perform 11/02/2023 -18.65% Morgan Stanley $23 → $22 Maintains Underweight 10/11/2023 -11.26% Deutsche Bank $26 → $24 Maintains Hold 10/06/2023 -14.96% Morgan Stanley $24 → $23 Maintains Underweight 08/08/2023 -11.26% Morgan Stanley $23 → $24 Maintains Underweight 08/01/2023 -9.41% Goldman Sachs $21.5 → $24.5 Maintains Sell 07/31/2023 -9.41% Goldman Sachs $21.5 → $24.5 Maintains Sell 07/31/2023 -0.17% BMO Capital $24 → $27 Maintains Market Perform 07/25/2023 -14.96% Morgan Stanley $23 → $23 Reiterates Underweight → Underweight 07/13/2023 -3.86% Wells Fargo $25.5 →
Franklin Resources (NYSE:BEN) Stock Analyst Ratings Read Post »
JPMorgan Chase & Co. (NYSE: JPM) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 35.27% Oppenheimer $232 → $238 Maintains Outperform 01/30/2024 25.61% Morgan Stanley $191 → $221 Maintains Overweight 01/16/2024 31.86% Oppenheimer $234 → $232 Maintains Outperform 01/16/2024 13.68% Piper Sandler $190 → $200 Maintains Overweight 01/16/2024 10.26% BMO Capital $192 → $194 Maintains Market Perform 01/09/2024 7.99% Deutsche Bank $140 → $190 Upgrades Hold → Buy 01/04/2024 6.85% B of A Securities $177 → $188 Maintains Buy 01/02/2024 20.5% Barclays $186 → $212 Maintains Overweight 12/18/2023 — Daiwa Capital Upgrades Outperform → Buy 11/16/2023 38.12% Oppenheimer $233 → $243 Maintains Outperform 10/16/2023 -3.38% Piper Sandler $168 → $170 Maintains Overweight 10/16/2023 -2.81% BMO Capital $167 → $171 Maintains Market Perform 10/16/2023 32.43% Oppenheimer $215 → $233 Maintains Outperform 10/16/2023 8.56% Morgan Stanley $187 → $191 Maintains Overweight 10/03/2023 6.29%
JPMorgan Chase & Co. (NYSE: JPM) Stock Analyst Ratings Read Post »
Morgan Stanley (NYSE:MS) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 24.7% Oppenheimer $106 → $109 Maintains Outperform 01/17/2024 21.27% Oppenheimer $107 → $106 Maintains Outperform 01/17/2024 22.41% BMO Capital $106 → $107 Maintains Outperform 01/17/2024 4.11% Keefe, Bruyette & Woods $102 → $91 Downgrades Outperform → Market Perform 01/17/2024 -0.47% JP Morgan $94 → $87 Downgrades Overweight → Neutral 01/09/2024 8.68% UBS $80 → $95 Maintains Neutral 01/09/2024 7.54% JP Morgan $92 → $94 Maintains Overweight 01/09/2024 9.83% HSBC → $96 Downgrades Buy → Hold 01/04/2024 14.4% B of A Securities $95 → $100 Maintains Buy 01/02/2024 32.71% Barclays $102 → $116 Maintains Overweight 12/21/2023 -2.76% RBC Capital → $85 Reiterates Sector Perform → Sector Perform 12/19/2023 14.4% Goldman Sachs $89 → $100 Maintains Buy 11/28/2023 -8.48% Societe Generale → $80 Downgrades Buy → Hold 11/20/2023 -2.76% Exane BNP Paribas
Morgan Stanley (NYSE:MS) Stock Analyst Ratings Read Post »
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target by $140 to $630, 36.6x our 2025 EPS estimate, a slight premium to MSCI’s 10-year forward P/E average of 36.0x. We raise our 2024 EPS view by $0.28 to $15.15 and start 2025’s at $17.20. MSCI posted Q4 adjusted EPS of $3.68 vs. $2.84, a $0.39 consensus beat. It was a strong quarter for MSCI as strong financial markets led to 12% growth in the Index segment (55% of run-rate). The Analytics segment (+7% and 26% of run-rate) showed improvement as economic uncertainty led to increased demand for MSCI’s risk management tools. MSCI’s retention rate improved 60 bps to 93.6%, while assets under management in equity ETF products linked to MSCI Indices reached an all-time record high of $1.47 trillion. Still, this
CFRA Maintains Hold Opinion On Shares Of Msci Inc. Read Post »
Bank of America (NYSE:BAC) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 21.16% Morgan Stanley $32 → $41 Upgrades Equal-Weight → Overweight 01/16/2024 0.18% Odeon Capital → $33.9 Downgrades Buy → Hold 01/16/2024 44.8% Oppenheimer $50 → $49 Maintains Outperform 01/16/2024 6.38% BMO Capital $37 → $36 Maintains Market Perform 01/02/2024 27.07% Barclays $39 → $43 Maintains Overweight 12/14/2023 12.12% Odeon Capital → $37.94 Upgrades Hold → Buy 12/01/2023 -2.48% Goldman Sachs $30 → $33 Maintains Buy 11/16/2023 50.71% Oppenheimer $49 → $51 Maintains Outperform 11/06/2023 -11.35% Keefe, Bruyette & Woods $29 → $30 Upgrades Underperform → Market Perform 10/18/2023 44.8% Oppenheimer $48 → $49 Maintains Outperform 10/18/2023 18.2% BMO Capital $39 → $40 Maintains Market Perform 10/03/2023 -5.44% Morgan Stanley $34 → $32 Maintains Equal-Weight 09/26/2023 41.84% Oppenheimer $49 → $48 Maintains Outperform 09/15/2023 -18.74% Piper Sandler $28 → $27.5
Bank of America (NYSE:BAC) Stock Analyst Ratings Read Post »
Morgan Stanley analyst Betsy Graseck upgrades Bank of America (NYSE:BAC) from Equal-Weight to Overweight and raises the price target from $32 to $41.
Morgan Stanley raises Bank of America (NYSE:BAC) price target from $32 to $41 Read Post »
Wells Fargo (NYSE:WFC) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 25% Morgan Stanley $54 → $63 Maintains Overweight 01/18/2024 -3.17% Odeon Capital → $48.8 Downgrades Buy → Hold 01/16/2024 -0.79% Piper Sandler $51 → $50 Maintains Neutral 01/16/2024 15.08% Raymond James $55 → $58 Maintains Strong Buy 01/09/2024 1.19% Deutsche Bank → $51 Downgrades Buy → Hold 01/08/2024 9.13% Baird → $55 Downgrades Outperform → Neutral 01/02/2024 30.95% Barclays $54 → $66 Maintains Overweight 12/14/2023 11.27% Odeon Capital → $56.08 Upgrades Hold → Buy 12/08/2023 -6.75% Piper Sandler $45 → $47 Maintains Neutral 12/06/2023 9.13% Raymond James $52 → $55 Maintains Strong Buy 12/04/2023 7.14% Morgan Stanley $52 → $54 Maintains Overweight 12/01/2023 -0.79% Goldman Sachs $45 → $50 Maintains Buy 10/16/2023 7.14% BMO Capital $52 → $54 Maintains Market Perform 09/22/2023 -12.7% Deutsche Bank $44 → $44 Reiterates Buy
Wells Fargo (NYSE:WFC) Stock Analyst Ratings Read Post »
JPMorgan Chase & Co. (NYSE: JPM) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 28.06% Morgan Stanley $191 → $221 Maintains Overweight 01/16/2024 34.43% Oppenheimer $234 → $232 Maintains Outperform 01/16/2024 15.89% Piper Sandler $190 → $200 Maintains Overweight 01/16/2024 12.41% BMO Capital $192 → $194 Maintains Market Perform 01/09/2024 10.09% Deutsche Bank $140 → $190 Upgrades Hold → Buy 01/04/2024 8.93% B of A Securities $177 → $188 Maintains Buy 01/02/2024 22.84% Barclays $186 → $212 Maintains Overweight 12/18/2023 — Daiwa Capital Upgrades Outperform → Buy 11/16/2023 40.8% Oppenheimer $233 → $243 Maintains Outperform 10/16/2023 -1.49% Piper Sandler $168 → $170 Maintains Overweight 10/16/2023 -0.92% BMO Capital $167 → $171 Maintains Market Perform 10/16/2023 35.01% Oppenheimer $215 → $233 Maintains Outperform 10/16/2023 10.67% Morgan Stanley $187 → $191 Maintains Overweight 10/03/2023 8.36% Morgan Stanley $179 → $187 Maintains Overweight 09/26/2023
JPMorgan Chase & Co. (NYSE: JPM) Stock Analyst Ratings Read Post »
MSCI Reports Financial Results for Fourth Quarter and Full Year 2023 NEW YORK–(BUSINESS WIRE)–January 30, 2024– MSCI Inc. (“MSCI” or the “Company”) (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, today announced its financial results for the three months ended December 31, 2023 (“fourth quarter 2023”) and full year ended December 31, 2023 (“full year 2023”). Financial and Operational Highlights for Fourth Quarter 2023 (Note: Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2022 (“fourth quarter 2022”) and Run Rate percentage changes are relative to December 31, 2022). — Operating revenues of $690.1 million, up 19.8%; Organic operating revenue growth of 14.7% — Recurring subscription revenues up 16.8%; Asset-based fees up 15.9% — Operating margin of 53.7%; Adjusted EBITDA margin of 60.1% — Diluted EPS of $5.07, up 89.9%; Adjusted EPS of $3.68,
MSCI Reports Financial Results for Fourth Quarter and Full Year 2023 Read Post »